A randomized clinical trial, ASPREE, indicates that patients 70 years of age or older who regularly take 100mg of aspirin daily "have a greater likelihood of being diagnosed with an advanced cancer and of dying from cancer." While researchers agree that further study is required, many believe that aspirin may indeed have a different effect on people as they age. Dr. Andrew Chan, senior researcher for ASPREE the strongly believes that "cancer prevention should be tailored to each person."
To read more about this study, click here.
No comments:
Post a Comment